What are the differences between amitriptyline and clomipramine regarding their therapeutic uses, pharmacologic profiles, and side‑effect patterns?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Differences Between Amitriptyline and Clomipramine

Both amitriptyline and clomipramine are tricyclic antidepressants (TCAs), but clomipramine is significantly more selective for serotonin reuptake inhibition, making it superior for obsessive-compulsive disorder, while amitriptyline has broader norepinephrine and serotonin effects with more pronounced anticholinergic side effects.

Pharmacologic Mechanism

Clomipramine is the most potent serotonin (5-HT) reuptake inhibitor among all TCAs 1, 2, 3. It functions as a relatively selective serotonin reuptake inhibitor (SRI), though it also affects norepinephrine to a lesser degree 4.

Amitriptyline is a tertiary amine TCA that inhibits reuptake of both norepinephrine and serotonin more equally 1. This dual action is less selective than clomipramine's predominantly serotonergic mechanism 5.

Both drugs are demethylated to active metabolites—clomipramine to desmethylclomipramine and amitriptyline to nortriptyline—which are then hydroxylated by CYP2D6 6.

Therapeutic Indications

Obsessive-Compulsive Disorder

Clomipramine demonstrates clear superiority for OCD treatment 7, 3. It is more effective than amitriptyline, imipramine, desipramine, and nortriptyline in reducing obsessive-compulsive symptoms 3. A controlled study showed clomipramine achieved a 95.2% improvement rate versus 55.6% for amitriptyline in OCD patients 8. This antiobsessional efficacy appears independent of antidepressant activity 3.

Depression

For depression, both drugs show comparable efficacy 9, 10. Meta-analyses indicate amitriptyline may have a slight edge in severely depressed or hospitalized patients 9. Amitriptyline is specifically recommended as first-line prophylaxis for migraine at 30-150 mg/day 11 and for cyclic vomiting syndrome at 25-150 mg nightly 12.

Neuropathic Pain

Amitriptyline is more established for neuropathic pain 5, 13. It is recommended for cancer-related neuropathic pain and central poststroke pain 5, 13. However, clomipramine (25-50 mg/day) shows efficacy for premature ejaculation 4 and may be superior for certain pain conditions like trigeminal neuralgia 14.

Panic Disorder

Clomipramine is effective for panic disorder, reducing panic attack frequency within 7-21 days with maintained efficacy for at least 12 months 3.

Dosing

Amitriptyline:

  • Depression: 30-150 mg/day 5
  • Migraine prophylaxis: 30-150 mg/day 11
  • CVS prophylaxis: Starting 25 mg nightly, goal 75-150 mg 12

Clomipramine:

  • OCD: Titrate to therapeutic doses (specific ranges not detailed in guidelines but typically 100-250 mg/day based on FDA labeling 2)
  • Premature ejaculation: 25-50 mg/day 4

Dose equivalence: Based on randomized trials, clomipramine 116.1 mg/day is approximately equivalent to amitriptyline 122.3 mg/day when compared to fluoxetine 40 mg/day as a reference 15.

Side Effect Profile

Amitriptyline has significantly more anticholinergic and antihistaminergic activity 5, 12. Common adverse effects include:

  • Somnolence, dry mouth, blurred vision, constipation, urinary hesitancy
  • Weight gain
  • Orthostatic hypotension
  • Prolonged QTc interval 12, 1

Clomipramine is better tolerated overall 8, 14, 3. While it shares typical TCA side effects, it produces:

  • Less cardiac toxicity than amitriptyline 16
  • Lower incidence of ventricular arrhythmias post-myocardial infarction 16
  • Dose-related seizure risk: 0.48% at ≤250 mg/day, 2.1% at ≥300 mg/day 3

A systematic review found patients on amitriptyline experienced more side effects than those on other antidepressants (odds ratio 0.63 favoring comparators) 10.

Clinical Considerations

For older adults: Both drugs require caution, but amitriptyline is considered potentially inappropriate per Beers Criteria due to pronounced anticholinergic effects 17. Secondary amine TCAs like nortriptyline (amitriptyline's metabolite) are safer alternatives 17.

Cardiac effects: Amitriptyline causes more pronounced intraventricular conduction slowing and increased arrhythmia risk, especially post-MI 16. Both prolong QTc and require ECG monitoring 12, 1.

Drug interactions: Both are metabolized by CYP2D6 and CYP2C19, requiring dose adjustments based on genetic polymorphisms 6. Clomipramine exhibits nonlinear pharmacokinetics at higher doses, potentially leading to dramatically elevated plasma concentrations 2.

Receptor selectivity: Amitriptyline shows 25-80 fold higher affinity for α1A-adrenoceptors and 10-25 fold higher for α1D-adrenoceptors compared to α1B-adrenoceptors 18, which may contribute to its orthostatic hypotension risk.

Key Pitfalls

  • Do not use amitriptyline as first-line for OCD—clomipramine is definitively superior 7, 8, 3
  • Avoid amitriptyline in elderly patients when alternatives exist due to high anticholinergic burden 17
  • Monitor for seizures with clomipramine, especially above 250 mg/day 3
  • Both require slow titration (10-25 mg increments every 2 weeks) to minimize side effects 12
  • Taper gradually when discontinuing to avoid withdrawal symptoms 1
  • Screen for cardiac conduction abnormalities before initiating either drug, particularly in post-MI patients 16

References

Guideline

adult cancer pain.

Journal of the National Comprehensive Cancer Network : JNCCN, 2010

Guideline

obsessive-compulsive disorder.

Nature Reviews Disease Primers, 2019

Research

[A control study of clomipramine and amitriptyline for treating obsessive-compulsive disorder].

Zhonghua shen jing jing shen ke za zhi = Chinese journal of neurology and psychiatry, 1991

Research

Amitriptyline versus other types of pharmacotherapy for depression.

The Cochrane database of systematic reviews, 2003

Research

Clomipramine and amitriptyline in the treatment of severe pain.

The International journal of neuroscience, 1979

Related Questions

Is the information that sertraline (selective serotonin reuptake inhibitor) is the first‑line antidepressant for older adults and that tricyclic antidepressants such as amitriptyline and doxepin should be avoided because of anticholinergic effects, sedation, and increased fall risk according to the Beers criteria accurate?
How to switch from amitriptyline (tricyclic antidepressant) 25 mg to clomipramine (tricyclic antidepressant) 25 mg?
In a 20-year-old male with depression and anxiety who stopped escitalopram (Lexapro) because of side effects, what alternative medication options are appropriate?
What dose of clonazepam is equivalent to alprazolam 1 mg taken three times daily?
For an 84-year-old female on sertraline (Zoloft) 200 mg daily with persistent anxiety and depression, what is an appropriate cross‑taper schedule to switch to escitalopram (Lexapro)?
What is the appropriate treatment for a 64-year-old woman with a distal medial tibial pilon fracture extending into the tibial plafond?
When should the chromic‑gut sutures placed in the buccal mucosa and the ethilon (nylon) skin sutures placed on a 1 cm lip laceration be removed?
Can amlodipine cause gum swelling or gingivitis as a side effect?
Is clomipramine recommended for patients with comorbid bipolar mania and severe obsessive‑compulsive disorder?
Does amitriptyline increase the risk of manic episodes in individuals with bipolar disorder or a predisposition to bipolarity?
For a patient with adjustment disorder with depressed mood (F43.21) and unspecified anxiety disorder (F41.9), is starting sertraline 50 mg daily and adding eszopiclone 2 mg at bedtime an appropriate treatment plan?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.